| Followers | 70 |
| Posts | 1643 |
| Boards Moderated | 1 |
| Alias Born | 01/27/2012 |
Saturday, May 05, 2012 12:12:50 AM
http://www.thestar.com/iphone/business/article/1173418--facebook-ipo-why-social-media-giant-feels-a-little-like-1999
Facebook Inc. shares could surge after its highly-anticipated stock market debut on May 18, but experts say enthusiasm will quickly wane if the company fails to come up with a plan to generate profits from advertising on mobile devices.
YOU REALLY THINK FACEBOOK HASN'T THOUGHT THIS THROUGH?
While roughly 500 million of Facebook’s more than 900 million monthly users log on to the social networking website via mobile handsets, the company in its IPO filings disclosed that “we do not currently directly generate revenue from the use of Facebook mobile products, and our ability to do so successfully is unproven.”
WOW, A COMPANY THAT KNOWS AND ADMITS ITS SHORTCOMINGS!
SO WHY NOT ACQUIRE A COMPANY WHO HAS PROVEN THEY CAN MONETIZE MOBILE?
APR 2011...DIDN'T WE SAY THE OTHER NIGHT THAT SPYDER HAS BEEN EMPLOYED FOR A YEAR NOW IN BETA MODE?
http://wiki.blucigs.com/256/blu-cigs-news/blu-cigs-selects-atrinsic/
The Atrinsic Affiliate Network, which recently upgraded its platform to incorporate the industry’s most advanced tracking technology, provides multi-level and reliable reporting and fraud protection services to increase ROI and protect brand integrity. The network platform also features cutting-edge ‘emerging channels functionality including capabilities in mobile that includes tracking and reporting, ad delivery and opt-in mobile number acquisition, as well as the ability to track affiliate sales through online video, rich media and social media integration.[/b]
SOUNDS EXACTLY LIKE A PRODUCT/SERVICE THAT FACEBOOK COULD USE GOING INTO ITS INFANCY IPO STAGE TO HELP GENERATE REVENUE THROUGH MOBILE SERVICES!
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
